Enliven Therapeutics (ELVN) Stock
Enliven Therapeutics (ELVN) closed at $47.62 on Nov 16, 2026; its Tenet Score is 59 of 100 against 313 Healthcare peers.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $47.62
- Nov 16, 2026
- Market cap
- $3.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 14.79 – 62.32
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 59/100
- Mixed · 313 Healthcare peers
Industry: Drugs
Enliven Therapeutics Inc scores 59/100. Mixed. Strongest on financial health, quality is the soft spot versus 313 Healthcare peers. Insufficient inputs: Tenet 59 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=313Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ~ Drawdown Context
- ~ Reversal Evidence
- ~ Not-a-Value-Trap Gate
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being eva…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Relay Therapeutics IncRLAY | 43 | $4.0B |
| Xenon Pharmaceuticals IncXENE | 44 | $4.0B |
| Tarsus Pharmaceuticals IncTARS | 33 | $4.0B |
| Amylyx Pharmaceuticals IncAMLX | 55 | $3.9B |
| Viking Therapeutics IncVKTX | 36 | $3.7B |
| Organon & Co.OGN | 45 | $3.7B |
| Iovance Biotherapeutics IncIOVA | 52 | $3.6B |
| Arcutis Biotherapeutics IncARQT | 43 | $3.6B |
| Supernus Inc.SUPN | 52 | $3.5B |
| Acadia Pharmaceuticals IncACAD | 65 | $3.2B |
Common questions
What sector and industry is Enliven Therapeutics in?
Enliven Therapeutics is in the Healthcare sector and the Drugs industry.
What is Enliven Therapeutics' Tenet Score?
Enliven Therapeutics' Tenet Score is 59 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




